- Home
- DLTH vs FBRX Comparison
DLTH vs FBRX Comparison
Compare DLTH & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLTH
- FBRX
- Stock Information
- Founded
- DLTH 1989
- FBRX N/A
- Country
- DLTH United States
- FBRX United States
- Employees
- DLTH N/A
- FBRX N/A
- Industry
- DLTH Clothing/Shoe/Accessory Stores
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- DLTH Consumer Discretionary
- FBRX Health Care
- Exchange
- DLTH Nasdaq
- FBRX Nasdaq
- Market Cap
- DLTH 71.0M
- FBRX 69.7M
- IPO Year
- DLTH 2015
- FBRX N/A
- Fundamental
- Price
- DLTH $2.09
- FBRX $10.55
- Analyst Decision
- DLTH Hold
- FBRX Strong Buy
- Analyst Count
- DLTH 1
- FBRX 2
- Target Price
- DLTH $2.75
- FBRX $61.00
- AVG Volume (30 Days)
- DLTH 38.7K
- FBRX 187.7K
- Earning Date
- DLTH 08-28-2025
- FBRX 08-13-2025
- Dividend Yield
- DLTH N/A
- FBRX N/A
- EPS Growth
- DLTH N/A
- FBRX N/A
- EPS
- DLTH N/A
- FBRX N/A
- Revenue
- DLTH $612,649,000.00
- FBRX N/A
- Revenue This Year
- DLTH N/A
- FBRX N/A
- Revenue Next Year
- DLTH N/A
- FBRX N/A
- P/E Ratio
- DLTH N/A
- FBRX N/A
- Revenue Growth
- DLTH N/A
- FBRX N/A
- 52 Week Low
- DLTH $1.58
- FBRX $4.11
- 52 Week High
- DLTH $4.50
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- DLTH 51.30
- FBRX 44.73
- Support Level
- DLTH $2.01
- FBRX $10.15
- Resistance Level
- DLTH $2.33
- FBRX $13.20
- Average True Range (ATR)
- DLTH 0.11
- FBRX 1.89
- MACD
- DLTH 0.01
- FBRX -0.38
- Stochastic Oscillator
- DLTH 42.86
- FBRX 4.72
About DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).